Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITEDLikely | 55 | ₹660 |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 13 | - |
| 3 | Schedule 3 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITEDLikely | 54 | ₹970.50 |
| 4 | Schedule 4 | SUNITA MEDICAL & PROVISION STORELikely | 55 | ₹1,159.20 |
| 5 | Schedule 5 | JAIPUR AGENCIESLikely | 55 | ₹2,958 |
Tender Value
₹90,966
EMD Value
Exempted
Closing Date
3 Jun 2025, 12:00 pmClosed
Tab Quetiapine 100 mg
Vasopressin 20 unitsobiliqueml Inj 1ml ampoule
Vecuronium Bromide 4mgobiliqueml 1 ml Inj
Vit B 12 1500 mcgobiliqueml Inj Methylcobalamine
Terbinafine 1percent cream tube of 10 gm
7833454
GEM/2025/B/6224702
Two Packet Bid
Tab Quetiapine 100 mg
30 days
Rajasthan; Ajmer
Item wise evaluation
PRODUCT
3 documents required · 3 mandatory
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Tab Quetiapine 100 mg | AJMER | 600 | 30 days |
| Vasopressin 20 unitsobiliqueml Inj 1ml ampoule | AJMER | 30 | 30 days |
| Vecuronium Bromide 4mgobiliqueml 1 ml Inj | AJMER | 30 | 30 days |
| Vit B 12 1500 mcgobiliqueml Inj Methylcobalamine | AJMER | 180 | 30 days |
| Terbinafine 1percent cream tube of 10 gm | AJMER | 300 | 30 days |
Exempted
3 Jun 2025
13 May 2025
3 Jun 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7833454.pdf
GEM_BID
dglp_medicine_36_2025-05-13-11-29-49_4c70e1b283ea76d39f4837fd4b6cec6c.pdf
BOQ
dglp_medicine_36_2025-05-13-11-29-49_1a27dc299b7d2c3390bdbad10140529b.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .